Meihua International Medical Stock Fundamentals
MHUA Stock | USD 0.59 0.13 18.06% |
Meihua International Medical fundamentals help investors to digest information that contributes to Meihua International's financial success or failures. It also enables traders to predict the movement of Meihua Stock. The fundamental analysis module provides a way to measure Meihua International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Meihua International stock.
At present, Meihua International's EBIT is projected to decrease significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 4.6 M, whereas Interest Expense is forecasted to decline to about 157.9 K. Meihua | Select Account or Indicator |
Meihua International Medical Company Return On Asset Analysis
Meihua International's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Meihua International Return On Asset | 0.042 |
Most of Meihua International's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Meihua International Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition |
Meihua Net Tangible Assets
Net Tangible Assets |
|
Based on the latest financial disclosure, Meihua International Medical has a Return On Asset of 0.042. This is 100.48% lower than that of the Health Care Equipment & Supplies sector and 100.14% lower than that of the Health Care industry. The return on asset for all United States stocks is 130.0% lower than that of the firm.
Meihua International Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Meihua International's current stock value. Our valuation model uses many indicators to compare Meihua International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Meihua International competition to find correlations between indicators driving Meihua International's intrinsic value. More Info.Meihua International Medical is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.65 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Meihua International Medical is roughly 1.53 . At present, Meihua International's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Meihua International's earnings, one of the primary drivers of an investment's value.Meihua Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Meihua International's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Meihua International could also be used in its relative valuation, which is a method of valuing Meihua International by comparing valuation metrics of similar companies.Meihua International is currently under evaluation in return on asset category among its peers.
Meihua Fundamentals
Return On Equity | 0.0642 | ||||
Return On Asset | 0.042 | ||||
Profit Margin | 0.1 % | ||||
Operating Margin | 0.13 % | ||||
Current Valuation | 12.04 M | ||||
Shares Outstanding | 26.09 M | ||||
Shares Owned By Insiders | 56.47 % | ||||
Shares Owned By Institutions | 8.70 % | ||||
Number Of Shares Shorted | 317.08 K | ||||
Price To Earning | 13.75 X | ||||
Price To Book | 0.13 X | ||||
Price To Sales | 0.20 X | ||||
Revenue | 97.1 M | ||||
Gross Profit | 37.97 M | ||||
EBITDA | 15.77 M | ||||
Net Income | 11.59 M | ||||
Cash And Equivalents | 34.17 M | ||||
Cash Per Share | 1.43 X | ||||
Total Debt | 7.33 M | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 5.45 X | ||||
Book Value Per Share | 5.73 X | ||||
Cash Flow From Operations | 2.28 M | ||||
Short Ratio | 0.36 X | ||||
Earnings Per Share | 0.37 X | ||||
Number Of Employees | 617 | ||||
Beta | 0.53 | ||||
Market Capitalization | 18.77 M | ||||
Total Asset | 171.92 M | ||||
Retained Earnings | 94.64 M | ||||
Working Capital | 107.16 M | ||||
Net Asset | 171.92 M |
About Meihua International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Meihua International Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Meihua International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Meihua International Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for Next Year | ||
Current Deferred Revenue | -236.1 K | -247.9 K | |
Total Revenue | 97.1 M | 104.1 M | |
Cost Of Revenue | 64 M | 64.4 M | |
Sales General And Administrative To Revenue | 0.08 | 0.05 | |
Research And Ddevelopement To Revenue | 0.03 | 0.03 | |
Capex To Revenue | 0.05 | 0.07 | |
Revenue Per Share | 4.06 | 3.15 | |
Ebit Per Revenue | 0.15 | 0.24 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Meihua International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Meihua International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Meihua International Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Meihua International Medical Stock:Check out Meihua International Piotroski F Score and Meihua International Altman Z Score analysis. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Meihua International. If investors know Meihua will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Meihua International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.42) | Earnings Share 0.37 | Revenue Per Share 3.847 | Quarterly Revenue Growth (0.06) | Return On Assets 0.042 |
The market value of Meihua International is measured differently than its book value, which is the value of Meihua that is recorded on the company's balance sheet. Investors also form their own opinion of Meihua International's value that differs from its market value or its book value, called intrinsic value, which is Meihua International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Meihua International's market value can be influenced by many factors that don't directly affect Meihua International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Meihua International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Meihua International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Meihua International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.